Peptide Stack Metrics Guide
A comprehensive guide to all the critical metrics and parameters you need to assess before, during, and after peptide therapy for optimal results and safety.
Why Metrics Matter
Designing a safe and effective peptide stack requires careful evaluation of multiple interconnected metrics and parameters. This guide outlines all the critical factors that must be assessed before, during, and after peptide therapy to ensure optimal results and minimize risks. Systematic tracking enables optimization of results, minimizes risks, and ensures peptide stacks deliver desired outcomes while maintaining your health and safety.
Part 1: Baseline Health Metrics
Pre-Protocol Assessment
Before initiating any peptide stack, a comprehensive baseline assessment is essential to establish a starting point and identify contraindications.
Part 2: Peptide-Specific Efficacy Metrics
Track how well each peptide performs
Weight Loss & Fat Loss (GLP-1/GIP/Glucagon Agonists)
| Metric | Target | Frequency |
|---|---|---|
| Weekly Weight Loss | 1-2 lbs/week | Weekly |
| Monthly Weight Loss | 4-8 lbs/month | Monthly |
| Visceral Fat Loss | 10-15% in 16w | Baseline, 16w |
| Appetite Suppression Score | 7-9/10 | Weekly |
| GI Side Effects | Mild to none by week 4 | Daily |
Part 3: Safety and Tolerance Metrics
Ensure the stack is safe and well-tolerated
Adverse Event Monitoring
Action: Reduce dose, slow titration
Action: Adjust diet, fiber, hydration
Action: Check hydration, BP
Action: Check sleep, cortisol, thyroid
Action: Rotate sites, check technique
Action: Move CJC to morning
Hormonal Safety Ranges
GH may increase
Monitor for gynecomastia
Some peptides may elevate
Should normalize
CJC-1295 can affect
May increase slightly
Metabolic Safety Ranges
GLP-1 improves control
Should decrease with weight loss
Non-diabetic target
Improves with weight loss
May slightly increase
Should increase
Organ Function Safety
AST, ALT, Bilirubin, Albumin
Creatinine, BUN, eGFR >60
HR 60-100, BP <140/90
Glucose, Amylase, Lipase
TSH, Free T3, Free T4
Part 4: Lifestyle and Compliance Metrics
Track adherence and lifestyle factors
Nutrition
Exercise
Recovery
Compliance
Part 5: Comparative and Synergy Metrics
Assess how peptides work together
Stack Synergy Metrics
| Metric | Ideal Outcome | Frequency |
|---|---|---|
| Combined Weight Loss | Greater than sum of individual peptides | Monthly |
| Muscle Preservation Ratio | Maintain 80-90% lean mass during cut | Baseline, 16w |
| Recovery Enhancement | 40-60% faster than without healing peptides | Ongoing |
| Hormonal Balance | All hormones within optimal ranges | Baseline, 8w, 16w |
| Side Effect Reduction | Fewer/milder than single agents | Daily |
Individual Peptide Performance
| Peptide | Primary Metric | Target |
|---|---|---|
| Retatrutide | Weekly weight loss | 1.5-2 lbs/wk by wk 8 |
| AOD9604 | Stubborn fat loss | 10% in 12w |
| CJC-1295/Ipamorelin | IGF-1 elevation | 150-250 ng/mL |
| BPC-157 | Joint pain reduction | 50-80% reduction |
| TB-500 | Tissue repair | 30-50% faster |
| Epithalon | Telomerase activation | 1-3% telomere ↑ |
Part 6: Advanced Assessment Metrics
Sophisticated metrics for advanced practitioners
Genetic & Epigenetic
Advanced Imaging
Advanced Metabolic Testing
Part 7: Monitoring Schedule
Recommended testing timeline
Before Starting
- Complete blood work (CBC, CMP, lipids, hormones)
- Body composition (DEXA or BodPod)
- Cardiovascular assessment (BP, HR, EKG if >50)
- Metabolic testing (glucose, insulin, HbA1c)
- Thyroid panel
- Immune markers
Early Assessment
- Subjective assessment (side effects, appetite, energy)
- Weight and circumference measurements
- Resting heart rate and blood pressure
Mid-Protocol
- Blood work (lipids, glucose, insulin, hormones, liver/kidney)
- Body composition (DEXA or BodPod)
- Strength assessment (1RM testing)
- Subjective metrics (energy, recovery, mood)
Progress Check
- Blood work (comprehensive panel)
- Cardiovascular assessment (BP, HR, lipids)
- Immune markers
- Inflammatory markers (CRP, ESR)
Full Assessment
- Blood work (complete panel)
- Body composition (DEXA or BodPod)
- Strength assessment
- Advanced metrics (telomere length if available)
Decision Point
- Comprehensive reassessment
- Genetic/epigenetic markers if desired
- Decision: continue, modify, or discontinue
Decision-Making Framework
- • Continue current protocol
- • Add advanced metrics
- • Plan long-term maintenance
- • Continue protocol
- • Identify limiting factors
- • Retest in 4 weeks
- • Assess compliance
- • Check drug interactions
- • Retest in 2 weeks
- • Discontinue protocol
- • Investigate causes
- • Consider alternatives
Part 8: Red Flags and Safety Thresholds
Immediately discontinue and seek medical attention
Key Takeaways
Thorough baseline assessment to establish starting points
Regular monitoring at strategic intervals
Objective measurements combined with subjective assessments
Flexibility to adjust based on individual response
Medical supervision throughout the process
Lifestyle optimization and adherence tracking
By tracking these metrics systematically, you can optimize results, minimize risks, and ensure that peptide stacks deliver the desired outcomes while maintaining your health and safety.
Tracking FAQ
How do I know if a peptide protocol is working?
Decide what 'working' means before you start: pick measurable baselines (labs, weight, performance, sleep metrics), a review date, and a stopping rule. Anything real should show up in something you can measure — and a program that resists defining success is telling you something.
What labs matter for tracking?
It depends on the compound and goal — which is exactly why a licensed provider should choose the panel. Common anchors include metabolic labs (glucose, A1c, lipids) and relevant hormone panels, repeated at intervals your provider sets, not one-off snapshots.
How long before deciding something isn't working?
Set the horizon up front with your provider — many trial protocols evaluate in weeks-to-months windows with predefined checkpoints. Open-ended programs with no review date are how people spend a year on something inert.
Are wearables good enough for tracking?
Useful for trends (sleep duration, resting heart rate, activity), weak for absolutes. Treat wearable data as a conversation input for your provider, not a verdict — and never let a dashboard substitute for labs a protocol actually needs.